TCL Archive Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President. March 23, 2007
TCL Archive O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology April 28, 1978
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
